Login
Popular articles
Vol 65, No 2 (2020)
Vol 64, No 4 (2019)
Vol 65, No 1 (2020)
Vol 61, No 3 (2016)
Vol 64, No 2 (2019)
Keywords
COVID-19
SARS-CoV-2
acute leukemia
acute lymphoblastic leukemia
acute myeloid leukemia
adults
chemotherapy
children
chronic lymphocytic leukemia
chronic myeloid leukemia
essential thrombocythemia
hemophilia
hemostasis
minimal residual disease
multiple myeloma
prognosis
thrombosis
thrombotic thrombocytopenic purpura
treatment
von Willebrand disease
von Willebrand factor
125167, Moscow, New Zykovsky proezd. 4
National Medical Research Center for Hematology, Moscow, Russian Federation (Russia)
e-mail: o.levchenko@htjournal.ru
tel.: 8-926-816-3887
